(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MEDICIBIO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MEDICIBIO

ST13

US500000097153921

Class

42

Filing

97153921

Registration

7273494

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

22

Latest update

01/22/2024

Trademark type

Word

Nice classes

42

Filing date

12/02/2021

Registration date

01/16/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/16/2024

Last transaction

01/16/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

03

Owner location

Gyeonggi-do, KR

Examiner

CANTOR, JILLIAN

Law office

M80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

MediciBIO Co., LTD

Representatives

Sangwon Kim REVOLUTION IP, PLLC

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Medicine researchclinical research in the field of medicine against genetic and rare diseases; Medical research in the field of medicines; Providing information on the testinginspectionresearch of medical products; Laboratory research services relating to pharmaceuticals; Medical and scientific researchconducting clinical trials for others; Development of pharmaceutical preparations and medicine; Pharmaceutical research and development; Medical research; Technical consultancy in relation to research services relating to foods and dietary supplements; Research and development of technology for medicinal chemical manufacturing

Publications

History of USPTO decisions and trademark events.

22 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/22/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/16/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

01/16/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/31/2023

PUBO

PUBLISHED FOR OPPOSITION

10/31/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/11/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/27/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/27/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/27/2023

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

05/30/2023

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

03/13/2023

GNSL

LETTER OF SUSPENSION E-MAILED

03/13/2023

CNSL

SUSPENSION LETTER WRITTEN

03/13/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/09/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/08/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/08/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/12/2022

GNRT

NON-FINAL ACTION E-MAILED

09/12/2022

CNRT

NON-FINAL ACTION WRITTEN

09/12/2022

DOCK

ASSIGNED TO EXAMINER

09/12/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/07/2021

NWAP

NEW APPLICATION ENTERED

12/06/2021

Continuous trademark protection

Get notified about every new filing that threatens MEDICIBIO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.